Rob Dillard

DocwireNews

<p>A recent study shows that family members of patients hospitalized in the intensive care unit (ICU) with acute respiratory distress syndrome (ARDS) caused by SARS-CoV-2 (<a href="https://www.docwirenews.com/covid-19/the-covid-19-pandemic-has-increased-loneliness-in-older-women-in-the-u-s/">COVID-19</a>) have a higher risk of posttraumatic stress disorder (<a href="https://www.docwirenews.com/abstracts/detecting-presence-of-ptsd-using-sentiment-analysis-from-text-data/">PTSD</a>) compared to families of patients hospitalized with non-COVID associated ARDS, further highlighting the vast mental toll the respiratory disease takes on everybody. The findings <a href="https://jamanetwork.com/journals/jama/fullarticle/2789436">appeared</a> in JAMA.<p>Among patients hospitalized with COVID, one in five require treatment in the ICU. Those who survive often suffer physical, mental, and psychiatric symptoms. It is also known that family members of patients with ARDS incur a significant psychological burden, including anxiety, depression, and PTSD. However, as the study investigators noted, little is known about the specific experience of COVID-19 with respect to the mental well-being of family members.</p><h2>Assessment and Findings</h2><p>In this prospective cohort study, researchers focused on 23 ICUs in France from January 2020 to June 2020 (final follow-up concluded in October 2020). In total, the analysis enrolled 602 family members, and 307 patients. The primary endpoint of interest was stipulated as family member symptoms of PTSD at 90 days after ICU discharge, which they measured using the Impact of Events Scale-Revised scoring system, with 0 (best score) to 88 (worst score).</p><p>Secondary outcomes of interest were family member symptoms of anxiety and depression at 90 days, which was assessed utilizing the Hospital Anxiety and Depression Scale [0 (best) to 42 (worst)]. The investigators used to multivariable logistic regression models to discern the link between COVID-19 status and outcomes.</p><p>According to the results, compared with non&ndash;COVID-19 ARDS, family members of patients with COVID-19 ARDS had a markedly higher prevalence of symptoms of PTSD (35% vs 19%), symptoms of anxiety (41% vs 34%), and symptoms of depression (31% vs 18%). Subsequent to adjusting for age, sex, and level of social support, the investigators observed that COVID-19 ARDS was significantly associated with increased risk of PTSD-related symptoms in family members.</p><h2>Limitations and Conclusion</h2><p>The researchers noted five limitations to this analysis:</p><ul>
<li>First, being that the patients were admitted early on in pandemic, the results may not apply to subsequent seasons or family resilience as the pandemic persisted.</li>
<li>Second, because all participating ICUs belong to a research network with significant experience in enhancing family care in the ICU, it may underestimate ICUs that don&rsquo;t put as high an emphasis on family care.</li>
<li>Third, the study exclusively focused on ICUs in France; therefore, the findings may not correlate to countries with different ICU staffing, COVID protocols, and cultural approaches.</li>
<li>Fourth, not all patients met the strict criteria for ARDS.</li>
<li>Fifth, the study did not analyze responses from ICU clinical staff, which limited responses to only patients and family members.</li>
</ul><p>&ldquo;Among family members of patients hospitalized in the ICU with ARDS, COVID-19 disease, as compared with other causes of ARDS, was significantly associated with increased risk of symptoms of PTSD at 90 days after ICU discharge,&rdquo; the researchers concluded.</p><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
<p lang="en" dir="ltr"><a href="https://twitter.com/hashtag/ARDS?src=hash&amp;ref_src=twsrc%5Etfw">#ARDS</a> due to <a href="https://twitter.com/hashtag/COVID?src=hash&amp;ref_src=twsrc%5Etfw">#COVID</a>-19 was associated with a greater risk-adjusted rate of <a href="https://twitter.com/hashtag/PTSD?src=hash&amp;ref_src=twsrc%5Etfw">#PTSD</a> symptoms among family members compared with ARDS from other causes. <a href="https://t.co/dZkCFPp2Jj">https://t.co/dZkCFPp2Jj</a></p>
<p>&mdash; Martijn A. Spruit (@pulmonary_rehab) <a href="https://twitter.com/pulmonary_rehab/status/1494790323838595076?ref_src=twsrc%5Etfw">February 18, 2022</a></p>
</blockquote><p><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></p><blockquote class="twitter-tweet" data-width="500" data-dnt="true">
<p lang="en" dir="ltr">The impact of Covid-19 on patients and families is felt long after discharge home. <a href="https://twitter.com/hashtag/PTSD?src=hash&amp;ref_src=twsrc%5Etfw">#PTSD</a></p>
<p>Association of COVID-19 Acute Respiratory Distress Syndrome With Symptoms of Posttraumatic Stress Disorder in Family Members After ICU Discharge | JAMA | JAMA Network <a href="https://t.co/UYLh1dwyp6">https://t.co/UYLh1dwyp6</a></p>
<p>&mdash; Sarah Bernstein, MD, MHA, FAAP (@sbernsteinmd) <a href="https://twitter.com/sbernsteinmd/status/1494797487256707073?ref_src=twsrc%5Etfw">February 18, 2022</a></p>
</blockquote><p><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></p><p>&nbsp;</p><p>&nbsp;</p></p>


Areef Ishani, MD

Joel M. Topf, MD, FACP

Kidney Stones With Chlorthalidone Versus Hydrochlorothiazide

NKF Spring Clinical Meetings 2025

MarkAlain Déry, DO

Eric Griggs, MD

Measles in America: An Ongoing Problem

Infectious Disease

Roger Rodby, MD

Seldin Award Winner Advocates Online Education

Latest News

COVID-19 Associated with PTSD in Family Members of Hospitalized Patients

COVID-19

A recent study shows that family members of patients hospitalized in the intensive care unit (ICU) with acute respiratory distress syndrome (ARDS) caused by SARS-CoV-2 ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe